[1]
A. . Orsini, “PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment”, Acta Biomed, vol. 92, no. S4, p. e2021416, Mar. 2022, doi: 10.23750/abm.v92iS4.12665.